Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
1,831
1,716
1,555
1,376
1,221
1,073
Croissance des revenus (H/H)
-13%
10%
13%
13%
14%
-15%
Coût des ventes
1,333
1,255
1,144
1,015
884
787
Bénéfice brut
497
461
411
360
337
285
Vente, Général et Administration
119
141
129
126
141
108
Recherche et développement
50
50
57
59
52
48
Frais d'exploitation
251
237
232
219
221
185
Autres revenus (charges) non opérationnels
-57
-7
-4
-1
0
-1
Bénéfice avant impôts
117
147
105
76
101
86
Charge d'impôt sur le revenu
30
26
16
10
8
8
Bénéfice net
86
119
90
66
96
77
Croissance du bénéfice net
-36%
32%
36%
-31%
25%
-20%
Actions en circulation (diluées)
35.6
35.64
33.75
33.4
33.3
33.1
Variation des actions (H-H)
-1%
6%
1%
0%
1%
0%
EPS (dilué)
2.44
3.36
2.68
1.98
2.9
2.33
Croissance du EPS
-35%
25%
35%
-32%
24%
-20%
Flux de trésorerie libre
121
99
60
41
103
129
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
27.14%
26.86%
26.43%
26.16%
27.6%
26.56%
Marge opérationnelle
13.38%
12.99%
11.44%
10.17%
9.41%
9.31%
Marge bénéficiaire
4.69%
6.93%
5.78%
4.79%
7.86%
7.17%
Marge du flux de trésorerie libre
6.6%
5.76%
3.85%
2.97%
8.43%
12.02%
EBITDA
369
334
276
232
196
179
Marge EBITDA
20.15%
19.46%
17.74%
16.86%
16.05%
16.68%
D&A pour le résultat opérationnel
124
111
98
92
81
79
EBIT
245
223
178
140
115
100
Marge EBIT
13.38%
12.99%
11.44%
10.17%
9.41%
9.31%
Taux d'imposition effectif
25.64%
17.68%
15.23%
13.15%
7.92%
9.3%
Statistiques clés
Clôture préc.
$85.92
Prix d'ouverture
$87.13
Plage de la journée
$85.64 - $88.06
Plage de 52 semaines
$62 - $144.76
Volume
483.3K
Volume moyen
597.8K
BPA (TTM)
2.39
Rendement en dividend
--
Capitalisation boursière
$3.0B
Qu’est-ce que ITGR ?
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The company is headquartered in Plano, Texas and currently employs 11,000 full-time employees. The company went IPO on 2000-09-29. The firm serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.